Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis

Table 2

DAI and CMDI of three groups on different time (mean ± SD).

Time	Control group		Model group		Rosiglitazone-treatedgroup
	DAI	CMDI	DAI	CMDI	DAI	CMDI
7th day	0.06±0.14	0.00±0.00	2.89±0.00 *	4.83±0.55 *	2.69±0.25	4.51±0.41
14th day	0.08±0.14	0.00±0.00	2.41±0.25 *	4.07±0.75 *	1.89±0.35^Δ	3.42±0.52^Δ
21st day	0.00±0.00	0.00±0.00	2.09±0.25 *	3.03±0.52 *	1.53±0.25^Δ	2.00±0.55^Δ
35th day	0.00±0.00	0.00±0.00	1.63±0.46 *	2.33±0.52 *	0.72±0.28^Δ	1.50±0.55^Δ

Note: *𝑃<0.05 versus control group, ^Δ𝑃<0.05 versus model group.